Please assess the completion status of the following clinical trial:

Trial Title: Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All patients fulfilling ACS criteria with or without known diabetes.~Exclusion Criteria:~* Patients under 18 years old.~* Killip II class or SaO2 ≤ 90%.~* Blood creatinine ≥ 180 µmol/L~* Potassium serum ≥ 6.5 mmol/L.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- glucose insulin potassium (GIK) (Type: PLACEBO_COMPARATOR): Glucose + insulin +6 potassium (GIK) infusion (1000 ml of Glucose 10%, 20 UI Insulin, 70 mEq of Potassium) within 24 hours.
- GIK and intensive insulin therapy (Type: EXPERIMENTAL): GIK infusion (1000 ml of Glucose 10%, 20 UI Insulin, 70 mEq of Potassium) within 24 hours. Intravenous intensive insulin therapy is simultaneously administered according to our protocol in the ED
- Control group (Type: NO_INTERVENTION): No intervention and patients were treated with updated international recommendations of acute coronary syndrome.

Based on this trial design, predict the completion outcome and termination type (if applicable).